| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.55B | 37.66B | 35.07B | 32.87B | 30.73B | 28.55B |
| Gross Profit | 11.11B | 12.19B | 10.92B | 9.93B | 8.82B | 7.87B |
| EBITDA | 4.93B | 5.31B | 4.89B | 4.12B | 3.57B | 3.06B |
| Net Income | 2.41B | 2.49B | 2.34B | 2.13B | 1.55B | 1.11B |
Balance Sheet | ||||||
| Total Assets | 22.15B | 26.20B | 24.49B | 23.45B | 21.51B | 20.08B |
| Cash, Cash Equivalents and Short-Term Investments | 6.91B | 10.59B | 8.12B | 7.67B | 6.31B | 5.21B |
| Total Debt | 466.36M | 525.55M | 482.68M | 520.86M | 551.73M | 609.56M |
| Total Liabilities | 7.99B | 9.64B | 9.30B | 9.19B | 8.97B | 8.64B |
| Stockholders Equity | 14.15B | 16.56B | 15.18B | 14.26B | 12.53B | 11.43B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.60B | 3.25B | 2.70B | 2.37B | 2.04B |
| Operating Cash Flow | 0.00 | 4.20B | 3.89B | 3.64B | 2.91B | 2.65B |
| Investing Cash Flow | 0.00 | -422.42M | -1.34B | -2.36B | -1.13B | -1.70B |
| Financing Cash Flow | 0.00 | -1.32B | -2.12B | -761.14M | -687.86M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥15.84B | 7.21 | ― | 3.81% | 7.75% | 71.62% | |
76 Outperform | ¥42.16B | 15.10 | ― | 2.56% | 7.38% | 4.61% | |
76 Outperform | ¥32.97B | 17.48 | ― | 5.00% | 2.53% | -6.30% | |
75 Outperform | ¥42.56B | 6.09 | ― | 2.28% | 7.47% | 12.35% | |
71 Outperform | ¥36.81B | 17.68 | ― | 3.55% | 3.13% | 6.72% | |
69 Neutral | ¥2.01B | 51.26 | ― | 3.34% | 0.21% | -85.46% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |